 Yttrium (90Y) clivatuzumab tetraxetan

Yttrium (90Y) clivatuzumab tetraxetan is a radiolabeled monoclonal antibody that is used in targeted radiation therapy, specifically for the treatment of certain types of cancer. Here's a breakdown of its components: 1. **Yttrium-90 (90Y)**: This is a radioactive isotope of yttrium. It emits beta radiation, which can be used to destroy cancer cells in targeted therapy.